Laden...
| This week's FierceBiotech is brought to you by PWC. |
| Clinical trials in the New Health Economy: Digital tools and data driving awareness, engagement and retention |
| We invite you to read PwC Health Research Institute's latest report, Next-generation clinical trials: Digital tools, data and patient experiences for faster, cheaper and higher-quality R&D. New digital tools and services can help biopharmaceutical companies overcome the delays and bottlenecks endemic to drug research and development and can improve patient experiences and retention during clinical trials. Making trial participation more convenient and relevant to patients can help bring new drugs to market more rapidly and distinguish products in competitive therapeutic areas. Biopharmaceutical companies are exploring the use of remote data collection to bring clinical trials to patients, in their homes, to make participation more convenient and to attract traditionally underrepresented patient populations, such as minorities, the elderly and women. They are working to improve patient experiences in clinical trials as participation, especially in oncology, becomes more competitive. And they are working with electronic health records systems to better educate and engage physicians about new trial opportunities for patients. Biopharmaceutical companies should consider the following implications: Communicate early with regulators about trial design and protocols. Drug regulatory agencies in the US and Europe have expressed a willingness to work with trial sponsors to help design and enable remote data collection. Create an intelligent data environment. Maintaining strong data integrity during clinical trials—regardless of where a trial takes place—is critical. Trial sponsors should review their data and analytics capabilities and decide whether to build them out further or partner with data or technology providers to create an enterprise capability that will support clinical trials across different R&D programs and therapeutic areas. Build your own solution for more efficient trials Numerous traditional healthcare companies, nonprofits and new entrants are bringing unique capabilities to the clinical trial process, to accelerate patient recruitment, data collection and analysis, and access to new therapies. To download this report, please click here. Learn more about PwC's Health Research Institute. For more information, please reach out to either of our subject matter specialists below: Omar Chane Principal, Pharmaceuticals and Life Sciences Tim Pantello Managing Director, Pharmaceuticals and Life Sciences pwc.com | Privacy Statement | Legal Disclaimer | About site provider | Update Profile | |
| Want to reach 150,000+ FierceBiotech subscribers with your own message?
FierceMarkets, a division of Questex, LLC |
Laden...
Laden...
